Volume 33, Issue 10 pp. 1387-1393
Original Article

Viable tumor in postchemoradiation neck dissection specimens as an indicator of poor outcome

Ian Ganly MD, PhD

Ian Ganly MD, PhD

Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY

Search for more papers by this author
Jennifer Bocker MD

Jennifer Bocker MD

Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY

Search for more papers by this author
Diane L. Carlson MD

Diane L. Carlson MD

Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY

Search for more papers by this author
Salvatore D'Arpa MD

Salvatore D'Arpa MD

Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY

Search for more papers by this author
Maria Coleman BA

Maria Coleman BA

Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY

Search for more papers by this author
Nancy Lee MD

Nancy Lee MD

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY

Search for more papers by this author
David G. Pfister MD

David G. Pfister MD

Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY

Search for more papers by this author
Jatin P. Shah MD

Jatin P. Shah MD

Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY

Search for more papers by this author
Snehal G. Patel MD

Corresponding Author

Snehal G. Patel MD

Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY

Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NYSearch for more papers by this author
First published: 04 November 2010
Citations: 25

Abstract

Background

The objective of this study was to determine the prognostic significance of viable tumor in postchemoradiation neck dissection specimens in patients with squamous cell carcinoma of the laryngopharynx.

Methods

Retrospective analysis identified 181 patients treated with primary concurrent chemoradiation for carcinoma of the laryngopharynx at Memorial Sloan-Kettering Cancer Center between the years 1995 and 2005. Of these, 56 patients had a comprehensive neck dissection either as a planned or salvage procedure. Neck dissection specimens were analyzed by a single pathologist for the presence of viable tumor. The presence of viable tumor was correlated to the timing of neck dissection after chemoradiation and to tumor response. Overall survival (OS), disease-specific survival (DSS), and recurrence-free survival (RFS) were determined by the Kaplan–Meier method, and correlation to tumor viability was determined with the log-rank test.

Results

Nineteen (33%) patients had viable tumor in their neck dissection specimens. Viable tumor was higher in patients who had a less-than-complete response to chemoradiation compared with those who had a complete response (42% vs 25%, p = .1). There was no correlation to timing of neck dissection. The 5-year OS, DSS, and RFS were significantly lower in patients who had viable tumor in their neck dissection specimens (OS 49% vs 93%, p = .0005; DSS 56% versus 93%, p = .003; RFS 40% vs 75%, p = .004).

Conclusions

Patients with viable tumor in postchemoradiation neck dissection specimens had a poorer outcome compared with patients with no viable tumor. © 2010 Wiley Periodicals, Inc. Head Neck, 2010

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.